Gilead Sciences shares gain after topping expectations despite lower remdesivir sales
Go back to Gilead Sciences shares gain after topping expectations despite lower remdesivir sales| Gilead Sciences (NASDAQ: GILD) | Delayed: 65.27 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.27 | 52 Week High | $108.63 | |||
| Open | $65.27 | 52 Week Low | $71.39 | |||
| Day High | $65.27 | P/E | 36.06 | |||
| Day Low | $65.27 | EPS | $1.81 | |||
| Volume | 105 | |||||
